Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

QC NON-ASPIRIN 500 MG GELCAP

Acetaminophen
$0.0321per EA
OTC

Strength

500 mg/1

Manufacturer

Chain Drug Marketing Association

NDC

63868098710

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

6/21/2023

Active Ingredients

ACETAMINOPHEN

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M013

On Market Since

5/10/2004

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

+3.8%

5Y

+23.2%

All

+32.9%

Generic Alternatives

Save up to 19%

9 alternatives • Same active ingredient

PHARBETOL 500 MG TABLET
Generic
16103037606•Pharbest Pharmaceuticals, Inc.
$0.0260
Save 19%
PAIN RELIEF 500 MG CAPLET
Generic
36800048478•Topco Associates LLC
$0.0287
Save 10%
QC PAIN RELIEF 500 MG CAPLET
Generic
63868008405•Chain Drug Marketing Association
$0.0309
Save 4%
ACETAMINOPHEN 500 MG CAPLET
Generic
70000037303•Cardinal Health
$0.0336
+5% more
FT PAIN RELIEVER 500 MG CAPLET
Generic
70677113803•Strategic Sourcing Services LLC
$0.0343
+7% more
ACETAMINOPHEN 500 MG TABLET
Generic
00904673080•Major Pharmaceuticals
$0.0343
+7% more
GS PAIN RELIEF 500 MG CAPLET
Generic
00113048478•L. Perrigo Company
$0.0343
+7% more
GNP PAIN RELIEF 500 MG CAPLET
Generic
46122031278•AmerisourceBergen
$0.0343
+7% more
ACETAMINOPHEN 500 MG CAPLET
Generic
00536141348•Rugby Laboratories
$0.0343
+7% more

Related Drugs

Same classification

No related drugs found.

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy